Smithfield Trust Co - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 55 filers reported holding REATA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Smithfield Trust Co ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$371,000
-31.4%
6,6130.0%0.04%
-27.1%
Q3 2018$541,000
+67.5%
6,613
-28.5%
0.06%
+59.5%
Q2 2018$323,000
+70.0%
9,2440.0%0.04%
+60.9%
Q1 2018$190,000
-27.5%
9,2440.0%0.02%
-28.1%
Q4 2017$262,000
-8.7%
9,2440.0%0.03%
-17.9%
Q3 2017$287,000
-1.7%
9,2440.0%0.04%
-9.3%
Q2 2017$292,000
+39.7%
9,2440.0%0.04%
+30.3%
Q1 2017$209,000
+3.5%
9,2440.0%0.03%
-2.9%
Q4 2016$202,000
+61.6%
9,244
+94.8%
0.03%
+54.5%
Q3 2016$125,000
+33.0%
4,7460.0%0.02%
+22.2%
Q2 2016$94,0004,7460.02%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders